Cargando…

A study exploring critical pathways in clear cell renal cell carcinoma

Renal cell carcinoma (RCC) is the most lethal type of cancer in the urinary system and often presents as a metastatic disease. Furthermore, there are no effective treatments for the disease. Several studies based on gene expression profiling have been performed with the aim of gaining insights into...

Descripción completa

Detalles Bibliográficos
Autores principales: ZENG, ZISAN, QUE, TENGCHENG, ZHANG, JIANGE, HU, YANLING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861490/
https://www.ncbi.nlm.nih.gov/pubmed/24348776
http://dx.doi.org/10.3892/etm.2013.1392
_version_ 1782295648163332096
author ZENG, ZISAN
QUE, TENGCHENG
ZHANG, JIANGE
HU, YANLING
author_facet ZENG, ZISAN
QUE, TENGCHENG
ZHANG, JIANGE
HU, YANLING
author_sort ZENG, ZISAN
collection PubMed
description Renal cell carcinoma (RCC) is the most lethal type of cancer in the urinary system and often presents as a metastatic disease. Furthermore, there are no effective treatments for the disease. Several studies based on gene expression profiling have been performed with the aim of gaining insights into the pathogenesis of RCC; however, few studies have investigated RCC at the pathway level to search for the possible pathways involved in clear cell RCC (CCRCC). In this study, gene set enrichment analysis (GSEA) was conducted on microarray datasets from CCRCC tissue. DAVID functional enrichment analysis was performed based on the dysregulated genes that were identified in a meta-analysis performed on the microarray datasets from CCRCC tissue. In GSEA, 17 down- and 12 upregulated pathways coexisted in six datasets. The majority of the upregulated pathways were associated with the immune system. In addition, 32 dysregulated pathways were obtained from DAVID functional enrichment analysis, based on the abnormal genes identified by meta-analysis. This study demonstrated that cross-GSEA is a useful method for exploring the critical pathways involved CCRCC; however, an individual dataset with a small sample may introduce bias. A cross-GSEA based on certain well-designed datasets may be required to further the progress made in this study, following the analysis of its results.
format Online
Article
Text
id pubmed-3861490
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-38614902013-12-13 A study exploring critical pathways in clear cell renal cell carcinoma ZENG, ZISAN QUE, TENGCHENG ZHANG, JIANGE HU, YANLING Exp Ther Med Articles Renal cell carcinoma (RCC) is the most lethal type of cancer in the urinary system and often presents as a metastatic disease. Furthermore, there are no effective treatments for the disease. Several studies based on gene expression profiling have been performed with the aim of gaining insights into the pathogenesis of RCC; however, few studies have investigated RCC at the pathway level to search for the possible pathways involved in clear cell RCC (CCRCC). In this study, gene set enrichment analysis (GSEA) was conducted on microarray datasets from CCRCC tissue. DAVID functional enrichment analysis was performed based on the dysregulated genes that were identified in a meta-analysis performed on the microarray datasets from CCRCC tissue. In GSEA, 17 down- and 12 upregulated pathways coexisted in six datasets. The majority of the upregulated pathways were associated with the immune system. In addition, 32 dysregulated pathways were obtained from DAVID functional enrichment analysis, based on the abnormal genes identified by meta-analysis. This study demonstrated that cross-GSEA is a useful method for exploring the critical pathways involved CCRCC; however, an individual dataset with a small sample may introduce bias. A cross-GSEA based on certain well-designed datasets may be required to further the progress made in this study, following the analysis of its results. D.A. Spandidos 2014-01 2013-11-07 /pmc/articles/PMC3861490/ /pubmed/24348776 http://dx.doi.org/10.3892/etm.2013.1392 Text en Copyright © 2014, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
ZENG, ZISAN
QUE, TENGCHENG
ZHANG, JIANGE
HU, YANLING
A study exploring critical pathways in clear cell renal cell carcinoma
title A study exploring critical pathways in clear cell renal cell carcinoma
title_full A study exploring critical pathways in clear cell renal cell carcinoma
title_fullStr A study exploring critical pathways in clear cell renal cell carcinoma
title_full_unstemmed A study exploring critical pathways in clear cell renal cell carcinoma
title_short A study exploring critical pathways in clear cell renal cell carcinoma
title_sort study exploring critical pathways in clear cell renal cell carcinoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861490/
https://www.ncbi.nlm.nih.gov/pubmed/24348776
http://dx.doi.org/10.3892/etm.2013.1392
work_keys_str_mv AT zengzisan astudyexploringcriticalpathwaysinclearcellrenalcellcarcinoma
AT quetengcheng astudyexploringcriticalpathwaysinclearcellrenalcellcarcinoma
AT zhangjiange astudyexploringcriticalpathwaysinclearcellrenalcellcarcinoma
AT huyanling astudyexploringcriticalpathwaysinclearcellrenalcellcarcinoma
AT zengzisan studyexploringcriticalpathwaysinclearcellrenalcellcarcinoma
AT quetengcheng studyexploringcriticalpathwaysinclearcellrenalcellcarcinoma
AT zhangjiange studyexploringcriticalpathwaysinclearcellrenalcellcarcinoma
AT huyanling studyexploringcriticalpathwaysinclearcellrenalcellcarcinoma